{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:14:43Z","timestamp":1775276083321,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.breast.2020.10.011","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T03:10:37Z","timestamp":1603681837000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-9021","authenticated-orcid":false,"given":"Cem","family":"Onal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Findikcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan Cem","family":"Guler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Reyhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2020.10.011_bib1","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2020.10.011_bib2","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/cncr.21778","article-title":"Metastatic patterns in adenocarcinoma","volume":"106","author":"Hess","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2020.10.011_bib3","first-page":"246","article-title":"Invasive breast cancer","volume":"5","author":"Carlson","year":"2007","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.breast.2020.10.011_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/annonc\/mdi063","article-title":"Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications","volume":"16","author":"Puglisi","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/JCO.2008.15.0243","article-title":"Locally advanced and inflammatory breast cancer","volume":"26","author":"Chia","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib6","first-page":"552","article-title":"NCCN guidelines Updates: breast cancer","volume":"17","author":"Telli","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.breast.2020.10.011_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN guidelines insights: breast cancer, version 1.2017","volume":"15","author":"Gradishar","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.breast.2020.10.011_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317728285","article-title":"18F-FDG PET\/CT in breast cancer: evidence-based recommendations in initial staging","volume":"39","author":"Caresia Aroztegui","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.breast.2020.10.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11307-018-1181-3","article-title":"The evolving role of FDG-PET\/CT in the diagnosis, staging, and treatment of breast cancer","volume":"21","author":"Paydary","year":"2019","journal-title":"Mol Imag Biol"},{"issue":"Suppl 1","key":"10.1016\/j.breast.2020.10.011_bib10","article-title":"18F-FDG PET\/CT for staging and restaging of breast cancer","volume":"57","author":"Groheux","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.breast.2020.10.011_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/IGC.0b013e3182989483","article-title":"Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy","volume":"23","author":"Onal","year":"2013","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.breast.2020.10.011_bib12","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.semnuclmed.2017.09.001","article-title":"PET\/CT for staging; past, present, and future","volume":"48","author":"El-Galaly","year":"2018","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.breast.2020.10.011_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00003072-200004000-00007","article-title":"F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection","volume":"25","author":"Bakheet","year":"2000","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.breast.2020.10.011_bib15","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1378\/chest.07-1360","article-title":"Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines","volume":"132","author":"Silvestri","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.breast.2020.10.011_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1148\/radiol.2292021598","article-title":"Non-small cell lung cancer: dual-modality PET\/CT in preoperative staging","volume":"229","author":"Antoch","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2020.10.011_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/IGC.0b013e31827e00cc","article-title":"Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography\/computed tomography in patients with cervical cancer","volume":"23","author":"Onal","year":"2013","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.breast.2020.10.011_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2014.04.004","article-title":"The role of (18)F-FDG PET\/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma","volume":"85","author":"Lu","year":"2014","journal-title":"Lung Canc"},{"key":"10.1016\/j.breast.2020.10.011_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-011-1767-9","article-title":"18F-FDG PET\/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques","volume":"131","author":"Koolen","year":"2012","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2020.10.011_bib20","first-page":"1455","article-title":"18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome","volume":"46","author":"Tran","year":"2005","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.breast.2020.10.011_bib21","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1200\/JCO.2001.19.15.3516","article-title":"18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer","volume":"19","author":"Eubank","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"Juweid","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.2004.04.148","article-title":"Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group","volume":"22","author":"Wahl","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.breast.2020.10.011_bib24","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1148\/rg.27si075517","article-title":"FDG PET, PET\/CT, and breast cancer imaging","volume":"27","author":"Rosen","year":"2007","journal-title":"Radiographics"},{"key":"10.1016\/j.breast.2020.10.011_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-012-2179-1","article-title":"Locoregional lymph node involvement on 18F-FDG PET\/CT in breast cancer patients scheduled for neoadjuvant chemotherapy","volume":"135","author":"Koolen","year":"2012","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2020.10.011_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jso.20574","article-title":"Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer","volume":"94","author":"van Rijk","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.coc.0000128869.19357.9b","article-title":"Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC)","volume":"27","author":"Bellon","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib28","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ejca.2010.07.034","article-title":"Detection of extra-axillary lymph node involvement with FDG PET\/CT in patients with stage II-III breast cancer","volume":"46","author":"Aukema","year":"2010","journal-title":"Eur J Canc"},{"key":"10.1016\/j.breast.2020.10.011_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/cncr.22867","article-title":"The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer","volume":"110","author":"Chia","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2020.10.011_bib30","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/cncr.21359","article-title":"Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies","volume":"104","author":"Gennari","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2020.10.011_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0030-1271148","article-title":"Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?","volume":"60","author":"Sivrikoz","year":"2012","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.breast.2020.10.011_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejcts.2007.09.026","article-title":"Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography","volume":"33","author":"Al-Sarraf","year":"2008","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.breast.2020.10.011_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejcts.2009.04.003","article-title":"Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography","volume":"36","author":"Bille","year":"2009","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.breast.2020.10.011_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/JTO.0b013e318220c912","article-title":"Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial","volume":"6","author":"Darling","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.breast.2020.10.011_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000074207","article-title":"Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings","volume":"70","author":"Konishi","year":"2003","journal-title":"Respiration"},{"key":"10.1016\/j.breast.2020.10.011_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-00034924","article-title":"Impact of FDG PET on the management of TBC treatment. A pilot study","volume":"49","author":"Sathekge","year":"2010","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.breast.2020.10.011_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.lungcan.2004.06.017","article-title":"Surgical mediastinal staging in daily practice","volume":"47","author":"Smulders","year":"2005","journal-title":"Lung Canc"},{"key":"10.1016\/j.breast.2020.10.011_bib38","doi-asserted-by":"crossref","DOI":"10.1378\/chest.07-1362","article-title":"Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines","volume":"132","author":"Detterbeck","year":"2007","journal-title":"Chest"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:43:08Z","timestamp":1760776988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977620302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"alternative-id":["S0960977620302022"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2020.10.011","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2020.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}